Terms: = Ovarian cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Diagnosis
14 results:
1. [A Case Report of Metastatic Breast cancer with Peritoneal Metastasis and Massive Ascites Responding to cdk4/6 Inhibitor(Palbociclib)].
Yao S; Goi T; Takahashi M; Kono H; Yokoi S; Maeda H
Gan To Kagaku Ryoho; 2024 Feb; 51(2):214-216. PubMed ID: 38449417
[TBL] [Abstract] [Full Text] [Related]
2. [Recurrent Breast cancer with Bone Metastasis Effectively Treated with Abemaciclib plus Endocrine Therapy-A Case Report].
Adachi K; Nagae J; Kubota H; Suzuki S; Hirano T; Sakurai K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1845-1847. PubMed ID: 38303227
[TBL] [Abstract] [Full Text] [Related]
3. Trichodermin Induces G0/G1 Cell Cycle Arrest by Inhibiting c-Myc in ovarian cancer Cells and Tumor Xenograft-Bearing Mice.
Gao Y; Miles SL; Dasgupta P; Rankin GO; Cutler S; Chen YC
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065149
[TBL] [Abstract] [Full Text] [Related]
4. Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer.
de Boer R; Hui R; Lim E; Yeo B; Zdenkowski N
Asia Pac J Clin Oncol; 2020 Nov; 16 Suppl 5():3-14. PubMed ID: 33137857
[TBL] [Abstract] [Full Text] [Related]
5. A high serum-free fatty acid level is associated with cancer.
Zhang L; Han L; He J; Lv J; Pan R; Lv T
J Cancer Res Clin Oncol; 2020 Mar; 146(3):705-710. PubMed ID: 31773260
[TBL] [Abstract] [Full Text] [Related]
6. Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer.
Lange CA; Yee D
Endocr Relat Cancer; 2011 Aug; 18(4):C19-24. PubMed ID: 21613412
[TBL] [Abstract] [Full Text] [Related]
7. Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), cdk4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.
Buecher B; Gauthier-Villars M; Desjardins L; Lumbroso-Le Rouic L; Levy C; De Pauw A; Bombled J; Tirapo C; Houdayer C; Bressac-de Paillerets B; Stoppa-Lyonnet D
Fam Cancer; 2010 Dec; 9(4):663-7. PubMed ID: 20842456
[TBL] [Abstract] [Full Text] [Related]
8. High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.
Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Hillemanns P; Dörk T
Clin Genet; 2010 Oct; 78(4):364-72. PubMed ID: 20569256
[TBL] [Abstract] [Full Text] [Related]
9. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
Yang G; Rosen DG; Liu G; Yang F; Guo X; Xiao X; Xue F; Mercado-Uribe I; Huang J; Lin SH; Mills GB; Liu J
Clin Cancer Res; 2010 Aug; 16(15):3875-86. PubMed ID: 20505188
[TBL] [Abstract] [Full Text] [Related]
10. ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.
; Beral V; Doll R; Hermon C; Peto R; Reeves G
Lancet; 2008 Jan; 371(9609):303-14. PubMed ID: 18294997
[TBL] [Abstract] [Full Text] [Related]
11. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
[TBL] [Abstract] [Full Text] [Related]
12. Predictors of comprehensive surgical treatment in patients with ovarian cancer.
Goff BA; Matthews BJ; Larson EH; Andrilla CH; Wynn M; Lishner DM; Baldwin LM
Cancer; 2007 May; 109(10):2031-42. PubMed ID: 17420977
[TBL] [Abstract] [Full Text] [Related]
13. Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.
Wong C; Hempling RE; Piver MS; Natarajan N; Mettlin CJ
Obstet Gynecol; 1999 Mar; 93(3):372-6. PubMed ID: 10074982
[TBL] [Abstract] [Full Text] [Related]
14. The effect of tubal ligation on the incidence of epithelial cancer of the ovary.
Koch M; Starreveld AA; Hill GB; Jenkins H
Cancer Detect Prev; 1984; 7(4):241-5. PubMed ID: 6488215
[TBL] [Abstract] [Full Text] [Related]